ARHGAP36
Rho GTPase-activating protein 36
Also known as: FLJ30058, RHG36_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZRI8
- Gene
- ARHGAP36
- Ensembl
- ENSG00000147256
- Chromosome
- X
- Canonical length
- 547 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
OverviewNCBI Gene
Predicted to enable GTPase activator activity. Predicted to be involved in signal transduction. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
547 residues, UniProt reviewed canonical sequence.
>Q6ZRI8|ARHGAP36
1 MGGCIPFLKA ARALCPRIMP PLLLLSAFIF LVSVLGGAPG HNPDRRTKMV SIHSLSELER
61 LKLQETAYHE LVARHFLSEF KPDRALPIDR PNTLDKWFLI LRGQQRAVSH KTFGISLEEV
121 LVNEFTRRKH LELTATMQVE EATGQAAGRR RGNVVRRVFG RIRRFFSRRR NEPTLPREFT
181 RRGRRGAVSV DSLAELEDGA LLLQTLQLSK ISFPIGQRLL GSKRKMSLNP IAKQIPQVVE
241 ACCQFIEKHG LSAVGIFTLE YSVQRVRQLR EEFDQGLDVV LDDNQNVHDV AALLKEFFRD
301 MKDSLLPDDL YMSFLLTATL KPQDQLSALQ LLVYLMPPCH SDTLERLLKA LHKITENCED
361 SIGIDGQLVP GNRMTSTNLA LVFGSALLKK GKFGKRESRK TKLGIDHYVA SVNVVRAMID
421 NWDVLFQVPP HIQRQVAKRV WKSSPEALDF IRRRNLRKIQ SARIKMEEDA LLSDPVETSA
481 EARAAVLAQS KPSDEGSSEE PAVPSGTARS HDDEEGAGNP PIPEQDRPLL RVPREKEAKT
541 GVSYFFPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGAP36 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 167 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 167 nTPM
- adrenal gland: 100 nTPM
- hypothalamus: 77 nTPM
- basal ganglia: 9.8 nTPM
- skeletal muscle: 6.4 nTPM
- amygdala: 5.2 nTPM
Single-cell type
- lactotrophs: 151 nCPM
- adrenal medulla cells: 138 nCPM
- thyrotrophs: 106 nCPM
- thymic myoid cells: 68 nCPM
- somatotrophs: 42 nCPM
- other brain neurons: 38 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 311 nTPM
- hypothalamus: 284 nTPM
- midbrain: 97 nTPM
- medulla oblongata: 74 nTPM
- basal ganglia: 38 nTPM
- hippocampal formation: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARHGAP36.
Disease | AllUniProt
Conditions ARHGAP36 is implicated in, by any mechanism.
- Bazex-Dupre-Christol syndrome (BDCS) MIM:301845
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 105 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- positive regulation of intracellular signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGAP36 as an antibody target. Whether an autoantibody or antibody against ARHGAP36 could matter depends on whether native ARHGAP36 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGAP36 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARHGAP36 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...